Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission

Cited by papers we hold 26

• Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications · 2024
  No notice
• Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality · 2024
  No notice
• Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction · 2024
  No notice
• SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits · 2024
  No notice
• Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances · 2023
  No notice
• The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction · 2023
  No notice
• Molecular Mechanisms of Mitochondrial Quality Control in Ischemic Cardiomyopathy · 2023
  No notice
• Irisin ameliorates neuroinflammation and neuronal apoptosis through integrin αVβ5/AMPK signaling pathway after intracerebral hemorrhage in mice · 2022
  No notice
• SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways · 2022
  No notice
• An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors · 2022
  No notice
• Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis · 2022
  No notice
• Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure · 2021
  Corrected
• Ketone bodies: from enemy to friend and guardian angel · 2021
  No notice
• Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF‐β/Smad signalling in type 2 diabetic rats · 2021
  No notice
• Bax inhibitor 1 preserves mitochondrial homeostasis in acute kidney injury through promoting mitochondrial retention of PHB2 · 2020
  No notice
• AMPK, Mitochondrial Function, and Cardiovascular Disease · 2020
  No notice
• Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases · 2020
  No notice
• Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice · 2020
  No notice
• DNA-PKcs promotes alcohol-related liver disease by activating Drp1-related mitochondrial fission and repressing FUNDC1-required mitophagy · 2019
  No notice
• SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart · 2019
  No notice

and 6 more

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.